DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin
- PMID: 6607110
DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin
Abstract
There is a progressive loss of human T-lymphocyte viability upon incubation with deoxycoformycin, an adenosine deaminase inhibitor, and low concentrations of deoxyadenosine (drug concentration that reduced cell count at 48 hr after initiation to 50% of value for untreated control culture, less than 1 microM). The loss of viability was evidenced by vital staining with fluorescein diacetate and by changes in forward single light scatter measured by flow cytometry. This loss of lymphocyte viability is detectable 18 to 20 hr after the addition of deoxyadenosine and is earlier than has been reported by other investigators using trypan blue as the vital stain. Alkaline elution studies show that the incubation of T-lymphocytes with the combinations of deoxycoformycin and deoxyadenosine gives rise to DNA single-strand breaks. These DNA strand breaks are dose and time dependent and are readily detected 4 hr after the addition of deoxyadenosine. These DNA lesions are not observed with deoxycoformycin or deoxyadenosine alone. Incubations of T-lymphocytes with deoxycoformycin and deoxyadenosine (1 and 5 microM) for 7 hr result in DNA strand breaks with a frequency of 145 and 280 rad equivalents, respectively. Preliminary studies indicate that the ability of lymphocytes to repair this damage is dependent upon deoxyadenosine concentration and exposure time. The relationship of these DNA lesions to loss of lymphocyte viability in the presence of deoxycoformycin and deoxyadenosine remains to be established.
Similar articles
-
Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.Cancer Res. 1981 Jul;41(7):2677-82. Cancer Res. 1981. PMID: 6972800
-
Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.J Immunol. 1986 Apr 15;136(8):2839-43. J Immunol. 1986. PMID: 2870121
-
Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.Cancer Invest. 1985;3(3):225-33. doi: 10.3109/07357908509039783. Cancer Invest. 1985. PMID: 3873981
-
2'-deoxycoformycin. A new anticancer agent.Cancer Clin Trials. 1981;4(2):209-13. Cancer Clin Trials. 1981. PMID: 7018725 Review.
-
2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.Acta Pol Pharm. 1996 Jul-Aug;53(4):231-9. Acta Pol Pharm. 1996. PMID: 9415193 Review.
Cited by
-
Adenine ribo- and deoxyribonucleotide metabolism in human erythrocytes, B- and T-lymphocyte cell lines, and monocyte-macrophages.Proc Natl Acad Sci U S A. 1985 Oct;82(19):6682-6. doi: 10.1073/pnas.82.19.6682. Proc Natl Acad Sci U S A. 1985. PMID: 3863121 Free PMC article.
-
A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survival.J Immunol. 2012 Apr 15;188(8):3920-7. doi: 10.4049/jimmunol.1102587. Epub 2012 Mar 9. J Immunol. 2012. PMID: 22407915 Free PMC article.
-
Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.Cancer Chemother Pharmacol. 1992;30(1):65-9. doi: 10.1007/BF00686487. Cancer Chemother Pharmacol. 1992. PMID: 1586982
-
Potential immunological action of purine nucleoside analogues.Drugs. 1994;47 Suppl 6:57-62. doi: 10.2165/00003495-199400476-00009. Drugs. 1994. PMID: 7525190 Review.
-
dNTP pools imbalance as a signal to initiate apoptosis.Experientia. 1996 Oct 31;52(10-11):995-1000. doi: 10.1007/BF01920108. Experientia. 1996. PMID: 8917730 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials